Krisanaprakornkit Suttichai, Kimball Janet R, Dale Beverly A
Department of Oral Biology, School of Dentistry, University of Washington, Seattle, WA 98195, USA.
J Immunol. 2002 Jan 1;168(1):316-24. doi: 10.4049/jimmunol.168.1.316.
Stratified epithelia of the oral cavity are continually exposed to bacterial challenge that is initially resisted by neutrophils and epithelial factors, including antimicrobial peptides of the beta-defensin family. Previous work has shown that multiple signaling pathways are involved in human beta-defensin (hBD)-2 mRNA regulation in human gingival epithelial cells stimulated with a periodontal bacterium, Fusobacterium nucleatum, and other stimulants. The goal of this study was to further characterize these pathways. The role of NF-kappaB in hBD-2 regulation was investigated initially due to its importance in inflammation and infection. Nuclear translocation of p65 and NF-kappaB activation was seen in human gingival epithelial cells stimulated with F. nucleatum cell wall extract, indicating possible involvement of NF-kappaB in hBD-2 regulation. However, hBD-2 induction by F. nucleatum was not blocked by pretreatment with two NF-kappaB inhibitors, pyrrolidine dithiocarbamate and the proteasome inhibitor, MG132. To investigate alternative modes of hBD-2 regulation, we explored involvement of mitogen-activated protein kinase pathways. F. nucleatum activated p38 and c-Jun NH(2)-terminal kinase (JNK) pathways, whereas it had little effect on p44/42. Furthermore, inhibition of p38 and JNK partially blocked hBD-2 mRNA induction by F. nucleatum, and the combination of two inhibitors completely blocked expression. Our results suggest that NF-kappaB is neither essential nor sufficient for hBD-2 induction, and that hBD-2 regulation by F. nucleatum is via p38 and JNK, while phorbol ester induces hBD-2 via the p44/42 extracellular signal-regulated kinase pathway. Studies of hBD-2 regulation provide insight into how its expression may be enhanced to control infection locally within the mucosa and thereby reduce microbial invasion into the underlying tissue.
口腔复层上皮不断受到细菌挑战,最初由中性粒细胞和上皮因子抵御,包括β-防御素家族的抗菌肽。先前的研究表明,在受到牙周细菌具核梭杆菌和其他刺激物刺激的人牙龈上皮细胞中,多种信号通路参与人β-防御素(hBD)-2 mRNA的调控。本研究的目的是进一步表征这些通路。由于NF-κB在炎症和感染中的重要性,最初研究了其在hBD-2调控中的作用。在用具核梭杆菌细胞壁提取物刺激的人牙龈上皮细胞中观察到p65的核转位和NF-κB的激活,表明NF-κB可能参与hBD-2的调控。然而,具核梭杆菌诱导的hBD-2并未被两种NF-κB抑制剂(吡咯烷二硫代氨基甲酸盐和蛋白酶体抑制剂MG132)预处理所阻断。为了研究hBD-2调控的替代模式,我们探讨了丝裂原活化蛋白激酶通路的参与情况。具核梭杆菌激活了p38和c-Jun NH2-末端激酶(JNK)通路,而对p44/42影响很小。此外,抑制p38和JNK可部分阻断具核梭杆菌诱导的hBD-2 mRNA表达,两种抑制剂联合使用则完全阻断其表达。我们的结果表明,NF-κB对于hBD-2的诱导既非必需也不充分,具核梭杆菌对hBD-2的调控是通过p38和JNK,而佛波酯通过p44/42细胞外信号调节激酶通路诱导hBD-2。对hBD-2调控的研究有助于深入了解如何增强其表达以在黏膜局部控制感染,从而减少微生物向深层组织的侵袭。